Target intelligence / Profile preview

MicroRNA 196b (miR-196b)

Target
miR-196b
Molecular classification
microRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 196b (miR-196b) is a member of the miR-196 gene family, encoded within the HOXA gene cluster on chromosome 7p15.2 in humans. It acts by suppressing target messenger RNAs through the RNA-induced silencing complex (RISC), leading to translational inhibition or mRNA degradation. miR-196b tightly regulates genes critical for embryonic development, hematopoiesis, and apoptosis. In cancer, dysregulation of miR-196b promotes abnormal proliferation and survival, contributing to malignancy, particularly in MLL-rearranged leukemia, where its overexpression leads to a block in hematopoietic differentiation and enhanced proliferation. Conversely, in some contexts, miR-196b may act as a tumor suppressor by repressing the expression of oncogenic HOX genes. Its levels in patient tissue samples can serve as a prognostic biomarker, and modifications targeting its activity (e.g., antagomirs) are being explored preclinically as therapeutic approaches.

Other names
MIR196Bhsa-mir-196bMIRN196BmiRNA196BmicroRNA-196b
02

Mechanism of action

Antagomir or antisense inhibition of miR-196b blocks its activity, affecting cell proliferation and differentiation in leukemia. Potential for miRNA mimic or replacement therapy in contexts where miR-196b acts as a tumor suppressor.

03

Biological functions

Post-transcriptional gene regulationCell proliferationApoptosis (FAS-mediated apoptosis)DifferentiationCancer pathogenesis
04

Disease associations

Cancer (including leukemia, gastric cancer, colorectal cancer, uterine leiomyoma)Leukemogenesis (mixed lineage leukemia)Tumor suppression or oncogenesis depending on context
05

Safety considerations

Off-target effects due to broad miRNA target spectrumPotential for dysregulation leading to increased proliferation or differentiation block in hematopoietic progenitors
06

Interacting drugs

Experimental use of antagomirs (anti-miRNA molecules) may target miR-196b
07

Biomarkers

miR-196b expression levels for cancer prognosis (independent prognostic biomarker in cancers such as colorectal cancer)Overexpression is associated with MLL-associated leukemiasUpregulation in colorectal cancer tissue

Beyond the preview

Go deeper on MicroRNA 196b (miR-196b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 196b (miR-196b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call